Takeda Pharmaceutical Company Limited News

Latest Takeda Pharmaceutical Company Limited Stock News & TAK Headlines

Takeda Launches ORZEYFUL™ (oveporexton), the First and Only Medicine of Its Kind for Narcolepsy Type 1 Now Available in the United States

3 days ago | businesswire.com

Takeda Pharmaceutical Co. $TAK Shares Sold by Heritage Investors Management Corp

12 days ago | defenseworld.net

Takeda Pharmaceutical's Earnings Growth Has Yet To Translate To Higher Cash Flow

16 days ago | seekingalpha.com

What Takeda Pharmaceutical (TAK) Said on Its Q2 Earnings Call

16 days ago | marketbeat.com

Takeda Beats Earnings Forecasts and Hikes Outlook Despite Generic Overhang

16 days ago | benzinga.com

Takeda Pharmaceutical Company Limited (TAK) Q2 2026 Earnings Call Transcript

16 days ago | seekingalpha.com

Takeda Announces FY2026 First-Half Results Highlighting Launch Momentum and Pipeline Milestones

17 days ago | businesswire.com

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study

23 days ago | businesswire.com

Takeda's ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1

a month ago | businesswire.com

Takeda Remains A Buy, Boosted By Recent Narcolepsy Drug Approval And Robust Pipeline

a month ago | seekingalpha.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

TAK

Takeda Pharmaceutical Company Limited

$ 21.43

1.47%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated a day ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Takeda Pharmaceutical Company Limited News

Latest Takeda Pharmaceutical Company Limited Stock News & TAK Headlines

Download App

People Also Watch

Explore our Tools